J&J Gets CDSCO Panel Nod to study anticancer drug Cetrelimab Dr. Divya Colin16 Jun 2023 6:00 PM ISTNew Delhi: Pharmaceutical major Johnson and Johnson has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
Novartis gets CDSCO panel nod to study anticancer drug Asciminib Dr. Divya Colin29 May 2023 9:37 PM ISTNew Delhi: In line with the justification provided by the drug major Novartis, the Subject Expert Committee (SEC) functional under the Central Drug...
Dr Reddy's Gets CDSCO Panel Nod to Manufacture, Market Anticancer Drug Lenalidomide Capsules Dr. Divya Colin26 May 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major Dr. Reddy's Laboratories has got a green signal from the Subject Expert Committee (SEC)...
MSD Pharma Gets CDSCO Panel Nod for additional indication of anticancer drug Pembrolizumab Dr. Divya Colin23 May 2023 6:00 PM ISTNew Delhi: Based on the global clinical trial data presented by drug major, MSD Pharmaceuticals, the Subject Expert Committee (SEC) functional under...
Novartis gets CDSCO panel nod for Phase III CT of anticancer drug Ianalumab Dr. Divya Colin23 March 2023 6:00 PM ISTNew Delhi: In a significant development, pharmaceutical major Novartis has got the go-ahead from the Subject Expert Committee (SEC) functional under...
Roche gets CDSCO panel nod to import, market anticancer Drug Polatuzumab vedotin Dr. Divya Colin21 March 2023 6:00 PM ISTNew Delhi: In a significant development, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO)...
CDSCO Panel approves Phase IV CT of Hetero-Trastuzumab marketed formulation Dr. Divya Colin19 March 2023 6:00 PM ISTNew Delhi: Drug major Hetero Biopharma has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO panel seeks data for Eli Lilly's anticancer drug selpercatinib Dr. Divya Colin21 Feb 2023 6:00 PM ISTNew Delhi: In response to the drug major Eli Lilly's proposal to waive off Phase IV clinical trial in the country for the Selpercatinib 40 & 80mg...
Eli Lilly gets CDSCO panel nod to study anticancer drug Imlunestrant Dr. Divya Colin9 Feb 2023 6:00 PM ISTNew Delhi: The drug major, Eli Lilly has got approval from the Subject Expert Committee (SEC) functional under the Central Standard Drug Control...
Submit Phase IV CT protocol for Entrectinib: CDSCO panel tells Roche India Dr. Divya Colin2 Jan 2023 5:45 PM ISTNew Delhi: Rejecting the drug major Roche's alternative proposal to the Phase IV clinical trial of anti-cancer Entrectinib capsules of 100 mg and 200...
Novartis gets CDSCO Panel nod to market anticancer drug Trametinib and Dabrafenib for additional indication Dr. Divya Colin1 Jan 2023 5:45 PM ISTNew Delhi: In a significant development, the drug major Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the...
AstraZeneca gets CDSCO panel nod to study anticancer drug Datopotamab deruxtecan Dr. Divya Colin31 Dec 2022 5:45 PM ISTNew Delhi: Pharmaceutical major, AstraZeneca has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
